Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2010
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2384064C Vaccine against herpes simplex virus and human papilloma virus
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2353816C Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation
06/01/2010CA2352231C Stable, attenuated rabies virus mutants and live vaccines thereof
06/01/2010CA2332627C Porcine circovirus and parvovirus vaccine
06/01/2010CA2309925C Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
06/01/2010CA2288373C Human cerberus protein
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/28/2010CA2645455A1 A method of medically treating an individual
05/27/2010WO2010060100A2 Antibodies directed against calcium channel subunit alpha2/delta and mehtods using same
05/27/2010WO2010060026A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010WO2010059969A2 Anti-angiogenesis therapy for the treatment of breast cancer
05/27/2010WO2010059821A1 Anti-unc5b antibodies and methods of use
05/27/2010WO2010059787A1 Therapeutic protein formulations
05/27/2010WO2010059779A1 Tcl1 AS A TRANSCRIPTIONAL REGULATOR
05/27/2010WO2010059654A1 c-MET ANTIBODIES
05/27/2010WO2010059135A1 Anti-cancer microparticle
05/27/2010WO2010059046A1 Cross-beta structures as carriers in vaccines
05/27/2010WO2010058550A1 Therapeutic or prophylactic agent for liver diseases comprising anti-human ggt antibody
05/27/2010WO2010058517A1 NERVE CELL STIMULATOR COMPRISING IgG AND/OR Fc FRAGMENT OF IgG
05/27/2010WO2010058236A1 Recombinant inactivated viral vector vaccine
05/27/2010WO2010057985A2 Salmonella marker vaccine
05/27/2010WO2010057983A1 Salmonella marker vaccine
05/27/2010WO2010057882A2 Composition for producing anti-amyloid beta peptide antibodies with d-peptides
05/27/2010WO2010057501A1 Priming of an immune response
05/27/2010WO2010057447A1 Single-time vaccines
05/27/2010WO2010057251A1 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
05/27/2010WO2010040096A3 Agonists of toll-like receptor 5 for the treatment of graft-versus-host disease
05/27/2010WO2010038155A3 Antibodies against il-25
05/27/2010WO2010033866A3 Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
05/27/2010WO2010031519A8 Transcutaneous compositions for specific immuno-modulatory treatment
05/27/2010WO2010028096A3 Peptides presenting an epitope of an a domain of factor h binding protein
05/27/2010WO2010019914A3 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre
05/27/2010WO2010019718A3 Carrier nanoparticles and related compositions, methods and systems
05/27/2010WO2010019262A3 Polyvalent vaccine
05/27/2010WO2010014567A3 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
05/27/2010WO2010014241A3 Equine disease model for herpesvirus neurologic disease and uses thereof
05/27/2010WO2010013934A3 Senescence control composition containing extracellular matrix components, and senescence control method for senescent cells using same
05/27/2010WO2010007376A3 Compositions monovalent for cd28 binding and methods of use
05/27/2010WO2010005567A3 Notch1 receptor binding agents and methods of use thereof
05/27/2010WO2010003009A3 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors
05/27/2010WO2010002818A3 Malaria vaccine of self-assembling polypeptide nanoparticles
05/27/2010WO2010001409A3 Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same
05/27/2010WO2009155504A3 Methods for the modulation of angiogenesis
05/27/2010WO2009140649A3 Rab3b for the treatment and prevention of parkinson's disease
05/27/2010WO2009114040A3 Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses
05/27/2010WO2008070780A9 Antagonist antibodies against ephb3
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100130728 Taci-immunoglobulin fusion proteins
05/27/2010US20100130574 Neurodegenerative diseases and methods of modeling
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129414 Bioactive Agent Delivery Using Liposomes in Conjunction With Stent Deployment
05/27/2010US20100129410 Methods and Immunogenic Cell Preparations for Treating Antigen-Associated Diseases
05/27/2010US20100129409 Novel Prostate Kallikrein Allergen
05/27/2010US20100129408 Klebsiella pneumoniae attenuated virulence mutant and method of production
05/27/2010US20100129407 Tuberculosis Vaccine
05/27/2010US20100129406 Holin-enhanced vaccines and reagents, and methods of use thereof
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129404 Immediate protection against pathogens via mva
05/27/2010US20100129403 Recombinant viral vaccine
05/27/2010US20100129402 Double-effective vaccine vector against foot-and-mouth disease virus (fmdv), methods of preparing and using the same
05/27/2010US20100129401 Functional Influenza Virus Like Particles (VLPs)
05/27/2010US20100129400 Attenuated viruses, vaccines and methods of use thereof
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129398 Materials and Methods for Control of Porcine Reproductive and Respiratory Syndrome
05/27/2010US20100129397 Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
05/27/2010US20100129396 V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity
05/27/2010US20100129395 Hapten-carrier conjugates and uses thereof
05/27/2010US20100129392 Targeting of Antigen Presenting Cells with Immunonanotherapeutics
05/27/2010US20100129391 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof
05/27/2010US20100129390 Dkk1 as a universal tumor vaccine for immunotherapy of cancers
05/27/2010US20100129389 Methods of modulating hvem, btla and cd160 cis complex response or signaling activity with soluble light polypeptide sequences
05/27/2010US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
05/27/2010US20100129387 Pharmaceutical composition containing the nmb0606 protein
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129385 Immunogenic molecules
05/27/2010US20100129384 Taci-immunoglobulin fusion proteins
05/27/2010US20100129383 Bifunctional fusion molecules for the delivery of antigens to professional antigen-presenting cells
05/27/2010US20100129382 Combination therapy for the treatment of tumors
05/27/2010US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129379 Stabilized antibody formulations and uses thereof
05/27/2010US20100129378 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
05/27/2010US20100129377 Milk derived antigen-specific antibodies, methods of preparation and uses thereof
05/27/2010US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof
05/27/2010US20100129375 Methods for inhibiting ocular angiogenesis
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129373 Vegf-specific human antibody
05/27/2010US20100129372 Inhibition of pacap signalling for the prevention and treatment of thrombocytopenia
05/27/2010US20100129371 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method
05/27/2010US20100129370 Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
05/27/2010US20100129369 c-Met Antibodies
05/27/2010US20100129368 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
05/27/2010US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
05/27/2010US20100129366 Thiazole inhibitors of cyclooxygenase
05/27/2010US20100129365 Treatment of inflammation using bst2 inhibitor
1 ... 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 ... 1823